754 related articles for article (PubMed ID: 26923959)
1. [Ebola vaccine and treatment].
Takada A
Uirusu; 2015; 65(1):61-70. PubMed ID: 26923959
[TBL] [Abstract][Full Text] [Related]
2. [Ebola vaccine, therapeutics, and diagnostics].
Furuyama W; Takada A
Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
4. Basic science and the Ebola virus infection epidemic.
DeVane CL
Pharmacotherapy; 2014 Nov; 34(11):1115-7. PubMed ID: 25382095
[No Abstract] [Full Text] [Related]
5. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
[TBL] [Abstract][Full Text] [Related]
6. Ebola Virus: Pathogenesis and Countermeasure Development.
Furuyama W; Marzi A
Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
[TBL] [Abstract][Full Text] [Related]
7. Merck vaccine heads Ebola countermeasures.
Sheridan C
Nat Biotechnol; 2018 Jul; 36(7):563-565. PubMed ID: 29979662
[No Abstract] [Full Text] [Related]
8. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
9. Epidemics of Ebola virus infection. Introduction.
Selgelid MJ
Monash Bioeth Rev; 2014; 32(3-4):159-61. PubMed ID: 25743057
[No Abstract] [Full Text] [Related]
10. Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus.
Baize S
Curr Opin Virol; 2015 Feb; 10():70-6. PubMed ID: 25666186
[TBL] [Abstract][Full Text] [Related]
11. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
Zhu X; Yao C; Wei Y; Kou Z; Hu K
Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
[TBL] [Abstract][Full Text] [Related]
12. [Ebola : an uncontrolled outbreak despite vaccines and new treatments].
Vetter P; Kaiser L
Rev Med Suisse; 2020 Apr; 16(690):739-743. PubMed ID: 32301308
[TBL] [Abstract][Full Text] [Related]
13. [Overview of the Ebola vaccines in pre-clinical and clinical development].
Buchy P
Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
[TBL] [Abstract][Full Text] [Related]
14. Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention.
Marcinkiewicz J; Bryniarski K; Nazimek K
Folia Med Cracov; 2014; 54(3):39-48. PubMed ID: 25694094
[TBL] [Abstract][Full Text] [Related]
15. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
16. Host Factors in Ebola Infection.
Rasmussen AL
Annu Rev Genomics Hum Genet; 2016 Aug; 17():333-51. PubMed ID: 27147086
[TBL] [Abstract][Full Text] [Related]
17. [Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone].
Watanabe T; Kawaoka Y
Uirusu; 2016; 66(1):53-62. PubMed ID: 28484179
[TBL] [Abstract][Full Text] [Related]
18. Transmission, Human Population, and Pathogenicity: the Ebola Case in Point.
Delgado R; Simón F
Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29573259
[TBL] [Abstract][Full Text] [Related]
19. Ebolavirus Evolution: Past and Present.
de La Vega MA; Stein D; Kobinger GP
PLoS Pathog; 2015; 11(11):e1005221. PubMed ID: 26562671
[TBL] [Abstract][Full Text] [Related]
20. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
